Analysts See $1.80 EPS for Rockwell Collins, Inc. (COL); Genomed Has 1.57 Sentiment

October 13, 2017 - By Vivian Currie

Analysts expect Rockwell Collins, Inc. (NYSE:COL) to report $1.80 EPS on October, 23.They anticipate $0.22 EPS change or 13.92% from last quarter’s $1.58 EPS. COL’s profit would be $293.73M giving it 18.74 P/E if the $1.80 EPS is correct. After having $1.64 EPS previously, Rockwell Collins, Inc.’s analysts see 9.76% EPS growth. The stock increased 0.25% or $0.34 during the last trading session, reaching $134.94. About shares traded. Rockwell Collins, Inc. (NYSE:COL) has risen 16.15% since October 13, 2016 and is uptrending. It has underperformed by 0.55% the S&P500.

Globus Medical, Inc. is a medical device company. The company has market cap of $2.76 billion. The Firm is focused on developing products for patients with musculoskeletal disorders. It has a 26.07 P/E ratio. It is focused on products to treat patients with spine disorders.

Ratings analysis reveals 50% of Globus Medical’s analysts are positive. Out of 4 Wall Street analysts rating Globus Medical, 2 give it “Buy”, 0 “Sell” rating, while 2 recommend “Hold”. GMED was included in 4 notes of analysts from November 9, 2016. The firm earned “Perform” rating on Wednesday, November 9 by Oppenheimer. The stock of Globus Medical Inc (NYSE:GMED) has “Outperform” rating given on Wednesday, April 12 by Leerink Swann. The stock of Globus Medical Inc (NYSE:GMED) earned “Buy” rating by Aegis Capital on Wednesday, November 30. The stock of Globus Medical Inc (NYSE:GMED) earned “Mkt Perform” rating by JMP Securities on Wednesday, November 9.

Consonance Capital Management Lp holds 11.07% of its portfolio in Globus Medical Inc for 2.84 million shares. Rk Asset Management Llc owns 119,036 shares or 3.31% of their US portfolio. Moreover, Pura Vida Investments Llc has 2.63% invested in the company for 200,000 shares. The Quebec – Canada-based Van Berkom & Associates Inc. has invested 2.37% in the stock. Paradigm Capital Management Inc Ny, a New York-based fund reported 786,100 shares.

The stock decreased 1.02% or $0.3 during the last trading session, reaching $29. About shares traded. Globus Medical Inc (GMED) has risen 30.88% since October 13, 2016 and is uptrending. It has outperformed by 14.18% the S&P500.

Analysts await Globus Medical Inc (NYSE:GMED) to report earnings on November, 14. They expect $0.30 earnings per share, up 3.45% or $0.01 from last year’s $0.29 per share. GMED’s profit will be $28.55 million for 24.17 P/E if the $0.30 EPS becomes a reality. After $0.32 actual earnings per share reported by Globus Medical Inc for the previous quarter, Wall Street now forecasts -6.25% negative EPS growth.

Since May 1, 2017, it had 0 insider buys, and 4 selling transactions for $1.89 million activity. The insider STURGELL ROBERT A sold 2,733 shares worth $284,232. $265,200 worth of stock was sold by KING BRUCE MICHAEL on Monday, May 1. Shares for $683,154 were sold by STANDERSKI JEFFREY A. on Thursday, June 1. The insider NIEUWSMA DAVID J sold 6,250 shares worth $656,250.

Among 22 analysts covering Rockwell Collins (NYSE:COL), 6 have Buy rating, 1 Sell and 15 Hold. Therefore 27% are positive. Rockwell Collins had 65 analyst reports since July 28, 2015 according to SRatingsIntel. The stock of Rockwell Collins, Inc. (NYSE:COL) earned “Hold” rating by RBC Capital Markets on Monday, May 29. The firm earned “Outperform” rating on Monday, September 21 by RBC Capital Markets. The firm has “Hold” rating given on Tuesday, September 5 by Deutsche Bank. The firm earned “Hold” rating on Wednesday, April 19 by Jefferies. Robert W. Baird maintained the stock with “Buy” rating in Tuesday, September 5 report. As per Monday, January 25, the company rating was maintained by RBC Capital Markets. The rating was maintained by Goldman Sachs on Wednesday, April 26 with “”. The firm has “Overweight” rating given on Monday, January 25 by Barclays Capital. On Thursday, January 19 the stock rating was initiated by SunTrust with “Hold”. The stock of Rockwell Collins, Inc. (NYSE:COL) has “Hold” rating given on Friday, April 21 by Canaccord Genuity.

Rockwell Collins, Inc. designs, produces and supports communications and aviation systems for commercial and military customers. The company has market cap of $22.02 billion. The Firm provides information management services through voice and data communication networks and solutions across the world. It has a 26.62 P/E ratio. The Firm operates through three divisions: Commercial Systems, Government Systems and Information Management Services.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Twitter Auto Publish Powered By : XYZScripts.com